Craig C. Hopkinson insider trades: Alkermes (ALKS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Craig reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | ALKS | ↓ Sell | 9,000 | $46.99 | $423K | Direct | Sep 1, 2026 (0d) |
| Aug 3, 2026 | ALKS | ↓ Sell | 9,000 | $48.58 | $437K | Direct | Aug 3, 2026 (0d) |
| Jul 1, 2026 | ALKS | ↓ Sell | 9,000 | $51.51 | $464K | Direct | Jul 1, 2026 (0d) |
| May 1, 2026 | ALKS | ↓ Sell | 9,000 | $33.40 | $301K | Direct | May 1, 2026 (0d) |
| Apr 1, 2026 | ALKS | ↓ Sell | 9,000 | $35.51 | $320K | Direct | Apr 1, 2026 (0d) |
| Mar 2, 2026 | ALKS | ↓ Sell | 9,000 | $29.72 | $267K | Direct | Mar 4, 2026 (2d) |
| Feb 2, 2026 | ALKS | ↓ Sell | 9,000 | $33.93 | $305K | Direct | Feb 2, 2026 (0d) |
| Jan 8, 2026 | ALKS | ↓ Sell | 5,000 | $30.00 | $150K | Direct | Jan 8, 2026 (0d) |
| Jan 2, 2026 | ALKS | ↓ Sell | 4,000 | $28.00 | $112K | Direct | Jan 2, 2026 (0d) |
| Dec 3, 2025 | ALKS | ↓ Sell | 3,748 | $30.00 | $112K | Direct | Dec 5, 2025 (2d) |
| Dec 1, 2025 | ALKS | ↓ Sell | 4,000 | $29.30 | $117K | Direct | Dec 1, 2025 (0d) |
| Nov 3, 2025 | ALKS | ↓ Sell | 9,000 | $30.38 | $273K | Direct | Nov 3, 2025 (0d) |
| Oct 15, 2025 | ALKS | ↓ Sell | 9,000 | $31.53 | $284K | Direct | Oct 15, 2025 (0d) |
| Feb 13, 2025 | ALKS | ↓ Sell | 349,340 | $33.92 | $11.8M | Direct | Feb 14, 2025 (1d) |
| Jan 30, 2025 | ALKS | ↓ Sell | 100,918 | $32.05 | $3.2M | Direct | Jan 31, 2025 (1d) |
| Dec 9, 2024 | ALKS | ↓ Sell | 61,151 | $32.07 | $2.0M | Direct | Dec 9, 2024 (0d) |
| Dec 5, 2024 | ALKS | ↓ Sell | 9,221 | $31.50 | $290K | Direct | Dec 5, 2024 (0d) |
| Dec 4, 2024 | ALKS | ↓ Sell | 14,349 | $30.77 | $442K | Direct | Dec 4, 2024 (0d) |
| Nov 11, 2024 | ALKS | ↓ Sell | 58,996 | $30.08 | $1.8M | Direct | Nov 12, 2024 (1d) |
| Nov 6, 2024 | ALKS | ↓ Sell | 10,471 | $29.53 | $309K | Direct | Nov 6, 2024 (0d) |
| Feb 23, 2022 | ALKS | ↓ Sell | 11,983 | $24.76 | $297K | Direct | Feb 24, 2022 (1d) |
| Feb 18, 2022 | ALKS | ↓ Sell | 2,306 | $25.17 | $58K | Direct | Feb 23, 2022 (5d) |
| Jun 9, 2021 | ALKS | ↓ Sell | 882 | $24.60 | $22K | Direct | Jun 11, 2021 (2d) |
| Apr 15, 2021 | ALKS | ↓ Sell | 28,920 | $19.72 | $570K | Direct | Apr 16, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALKS insiders
Open-market trades in the last 12 months
About Craig C. Hopkinson's insider trades
Craig C. Hopkinson is EVP R&D, Chief Medical Officer at Alkermes (ALKS). Since Apr 15, 2021, Craig has reported no open-market purchases and 24 sales worth $24.4M on SEC Form 4. In the last 12 months: 11 sales ($3.0M).
Their filings also include option exercises (36 filings), shares withheld for taxes (26 filings), grants and awards (16 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALKS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.